Lack Of TB Drugs At Rajan Babu TB Hospital: HC Closes PIL As Govt Ensures Supply
- byDoctor News Daily Team
 - 29 July, 2025
 - 0 Comments
 - 0 Mins
 
                            
                                    New Delhi: The Delhi High Court has concluded the proceedings on a Public Interest Litigation (PIL) concerning the alleged lack of medicines to treat TB patients at the MCD-run Rajan Babu Institute of Pulmonary Medicine and Tuberculosis.
This decision followed assurances provided to a division bench comprising Acting Chief Justice Manmohan and Justice Manmeet PS Arora, indicating that the current medicine stock in Delhi would suffice for several weeks and additional supplies were on the way.
According to an IANS news report, The PIL, filed by NGO Social Jurist earlier this year, alleged that the sole ultrasound machine at the hospital was non-functional and that essential medicines had been unavailable for the past six months. Advocate Ashok Agarwal, representing the petitioner, argued that the shortage forced poor patients to buy medicines from outside sources.
Also Read:Delhi HC dismisses plea by MCD Paramedical staff challenging app-based attendance system
The Central government and the Mission Director of the Delhi State Health Mission submitted affidavits detailing the stock levels and the supply pipeline for essential drugs. These submissions confirmed that immediate shortages were being addressed effectively.
"Keeping in view the fact that the stock in hand of 4 FDC (A) drug is good for a month and for 3 FDC (A) drug is good for three weeks and rest of the supply is in the pipeline, the present petition is disposed of as satisfied," the bench stated in its order.
Meanwhile, the Municipal Corporation of Delhi (MCD) assured the court that the ultrasound machine at the institute is now fully functional.
The court was informed that a CT scan machine was not required at the institute as patients below the poverty line were referred to Hindu Rao Hospital for free scans. Other patients could get scans at a nominal fee of Rs 1,500, typically covered by an NGO, news agency IANS reported.
Earlier, the Centre had assured the court of proactive measures to expedite the supply of anti-TB drugs to ensure uninterrupted patient care.
Also Read:No Salaries, No Drinking water: Delhi's Hindu Rao, Rajan Babu doctors call off strike after Govt's assurance
                                
    Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
    The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
    Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
    If you come across any inconsistencies, please reach out to us at 
    admin@doctornewsdaily.com.
    We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
    By using this website, you agree to our 
    Terms of Use, 
    Privacy Policy, and 
    Advertisement Policy.
    For further details, please review our 
    Full Disclaimer.
Recent News
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
 
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
 
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
 
Aadhaar authentication voluntary for NBE exams, cl...
- 02 November, 2025
 
Daily Newsletter
Get all the top stories from Blogs to keep track.
                    
                    
0 Comments
Post a comment
No comments yet. Be the first to comment!